Trial Profile
Clinical Trials Insight: 700023961
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2007
Price :
$35
*
At a glance
- Drugs Atacicept (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Sponsors ZymoGenetics
- 20 Jun 2007 New trial record.